Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
531 questions in 102 reviews · Gynaecology and Fertility
current versionsNo studies 531 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Summary of findings table ‐ Metformin + megestrol vs megestrol Abnormal uterine bleeding ‐ not measured · endometrial hyerplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Metformin + megestrol vs megestrol Health‐related quality of life (HRQoL) ‐ not measured · endometrial hyerplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Metformin + levonorgestrel (intrauterine system) vs levonorgestrel intrauterine system Recurrence of endometrial hyperplasia ‐ not reported · endometrial hyperplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Metformin vs megestrol Health‐related quality of life (HRQoL) ‐ not measured · endometrial hyperplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Metformin vs megestrol Adverse effects during treatment ‐ not reported · endometrial hyperplasia Metformin for endometrial hyperplasia (2024) · Cochrane | no estimate extracted | NR | No studies |
Intrauterine infusion of autologous platelet‐rich plasma vs intrauterine infusion of granulocyte colony‐stimulating factor Adverse events · women undergoing assisted reproduction Autologous platelet‐rich plasma for assisted reproduction (2024) · Cochrane | no estimate extracted | NR | No studies |
Intraovarian injection of autologous platelet‐rich plasma vs no intervention Miscarriage · women undergoing assisted reproduction Autologous platelet‐rich plasma for assisted reproduction (2024) · Cochrane | no estimate extracted | NR | No studies |
Intraovarian injection of autologous platelet‐rich plasma vs no intervention Adverse events · women undergoing assisted reproduction Autologous platelet‐rich plasma for assisted reproduction (2024) · Cochrane | no estimate extracted | NR | No studies |
NSAID vs combined OCP Pain improvement · women with primary dysmenorrhoea Combined oral contraceptive pill for primary dysmenorrhoea (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAID vs combined OCP Adverse events · women with primary dysmenorrhoea Combined oral contraceptive pill for primary dysmenorrhoea (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAID vs combined OCP Requirement for additional medication · women with primary dysmenorrhoea Combined oral contraceptive pill for primary dysmenorrhoea (2023) · Cochrane | no estimate extracted | NR | No studies |
NSAID vs combined OCP Absence from work or school · women with primary dysmenorrhoea Combined oral contraceptive pill for primary dysmenorrhoea (2023) · Cochrane | no estimate extracted | NR | No studies |
Combined low‐dose OCP vs another combined low‐dose OCP Requirement for additional medication · women with primary dysmenorrhoea Combined oral contraceptive pill for primary dysmenorrhoea (2023) · Cochrane | no estimate extracted | NR | No studies |
IVF vs expectant management Multiple pregnancy rate per woman randomised · women with unexplained subfertility In vitro fertilisation for unexplained subfertility (2023) · Cochrane | no estimate extracted | NR | No studies |
IVF vs expectant management OHSS rate per woman randomised · women with unexplained subfertility In vitro fertilisation for unexplained subfertility (2023) · Cochrane | no estimate extracted | NR | No studies |
IVF vs expectant management Miscarriage rate per woman randomised · women with unexplained subfertility In vitro fertilisation for unexplained subfertility (2023) · Cochrane | no estimate extracted | NR | No studies |
IVF vs unstimulated IUI OHSS rate per woman randomised · women with unexplained subfertility In vitro fertilisation for unexplained subfertility (2023) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic hysterectomy vs vaginal hysterectomy Long‐term outcomes · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Robotic hysterectomy vs laparoscopic hysterectomy Long‐term outcomes · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Robotic hysterectomy vs laparoscopic hysterectomy Long‐term complications (dichotomous) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Robotic hysterectomy vs laparoscopic hysterectomy Intra‐operative visceral injury (dichotomous) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Robotic hysterectomy vs laparoscopic hysterectomy Major short‐term complications (dichotomous) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐port laparoscopic hysterectomy vs laparoscopic hysterectomy Return to normal activities (days) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐port laparoscopic hysterectomy vs laparoscopic hysterectomy Long‐term outcomes · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐port laparoscopic hysterectomy vs laparoscopic hysterectomy Long‐term complications (dichotomous) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Single‐port laparoscopic hysterectomy vs laparoscopic hysterectomy Major short‐term complications (dichotomous) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Total laparoscopic hysterectomy vs laparoscopic‐assisted vaginal hysterectomy Return to normal activities (days) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Total laparoscopic hysterectomy vs laparoscopic‐assisted vaginal hysterectomy Long‐term outcomes · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Total laparoscopic hysterectomy vs laparoscopic‐assisted vaginal hysterectomy Long‐term complications (dichotomous) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
V‐NOTES vs laparoscopic hysterectomy Return to normal activities (days) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
V‐NOTES vs laparoscopic hysterectomy Long‐term outcomes · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
V‐NOTES vs laparoscopic hysterectomy Long‐term complications (dichotomous) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
V‐NOTES vs laparoscopic hysterectomy Major short‐term complications (dichotomous) · patients with benign gynaecological disease Surgical approach to hysterectomy for benign gynaecological disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Statin vs placebo Resumption of spontaneous ovulation · women with polycystic ovary syndrome not actively trying to conceive Statins for women with polycystic ovary syndrome not actively trying to conceive (2023) · Cochrane | no estimate extracted | NR | No studies |
Statin vs metformin Resumption of spontaneous ovulation · women with polycystic ovary syndrome not actively trying to conceive Statins for women with polycystic ovary syndrome not actively trying to conceive (2023) · Cochrane | no estimate extracted | NR | No studies |
Statin vs metformin Adverse effects · women with polycystic ovary syndrome not actively trying to conceive Statins for women with polycystic ovary syndrome not actively trying to conceive (2023) · Cochrane | no estimate extracted | NR | No studies |
Statin vs placebo Improvement in hirsutism · women with polycystic ovary syndrome not actively trying to conceive Statins for women with polycystic ovary syndrome not actively trying to conceive (2023) · Cochrane | no estimate extracted | NR | No studies |
Statin vs placebo Improvement in acne severity · women with polycystic ovary syndrome not actively trying to conceive Statins for women with polycystic ovary syndrome not actively trying to conceive (2023) · Cochrane | no estimate extracted | NR | No studies |
Hormonal therapy vs placebo or no intervention Estrogen + progestogens · symptomatic or early postmenopausal womena Hormone therapy for sexual function in perimenopausal and postmenopausal women (2023) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life – not reported · couples trying to conceive Timed intercourse for couples trying to conceive (2023) · Cochrane | no estimate extracted | NR | No studies |
GnRHas vs no treatment No studies included for any outcomes · Women with endometriosis Gonadotropin‐releasing hormone analogues for endometriosis (2023) · Cochrane | no estimate extracted | NR | No studies |
GnRHas vs intra‐uterine progestogens device No studies included with only low risk of bias · Women with pain due to endometriosis Gonadotropin‐releasing hormone analogues for endometriosis (2023) · Cochrane | no estimate extracted | NR | No studies |
GnRHas vs analgesics No studies included for any outcomes · Women with pain due to endometriosis Gonadotropin‐releasing hormone analogues for endometriosis (2023) · Cochrane | no estimate extracted | NR | No studies |
Blastocyst‐stage vs cleavage‐stage embryo transfer Outcomes per couple · women and couples with subfertility Cleavage‐stage versus blastocyst‐stage embryo transfer in assisted reproductive technology (2022) · Cochrane | no estimate extracted | NR | No studies |
Low vs high 17ß‐oestradiol dose Endometrial histology · young women with Turner syndrome who have completed pubertal induction Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency (2022) · Cochrane | no estimate extracted | NR | No studies |
Low vs high 17ß‐oestradiol dose Uterine perfusion · young women with Turner syndrome who have completed pubertal induction Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency (2022) · Cochrane | no estimate extracted | NR | No studies |
Low vs high 17ß‐oestradiol dose Reproductive outcomes · young women with Turner syndrome who have completed pubertal induction Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency (2022) · Cochrane | no estimate extracted | NR | No studies |
Oral vs vaginal administration of oestradiol and dydrogesterone Endometrial histology · women with premature ovarian insufficiency (POI) awaiting oocyte donation Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency (2022) · Cochrane | no estimate extracted | NR | No studies |
Oral vs vaginal administration of oestradiol and dydrogesterone Uterine perfusion · women with premature ovarian insufficiency (POI) awaiting oocyte donation Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency (2022) · Cochrane | no estimate extracted | NR | No studies |
Conjugated oral oestrogens vs transdermal 17ß‐estradiol Endometrial thickness · girls with Turner syndrome who were treated with prepubertal growth hormone Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency (2022) · Cochrane | no estimate extracted | NR | No studies |